Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3 β -mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy
Journal of Molecular Cell Biology · 2024
DOI: 10.1093/jmcb/mjad056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2024. Verfasst von Yingmei Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital Fudan University, Shanghai 710032, China. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Diabetes Mellitus, Experimental, Diabetic Cardiomyopathies, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Province and the Ministry, Scientific Research Initiation Project of Guangdong Provincial Hospital of Traditional Chinese Medicine, Fundamental and Applied Research.
Abstract (Originalsprache)
Mitochondrial aldehyde dehydrogenase (ALDH2) offers proven cardiovascular benefit, although its impact on diabetes remains elusive. This study examined the effects of ALDH2 overexpression and knockout on diabetic cardiomyopathy and the mechanism involved with a focus on mitochondrial integrity. Mice challenged with streptozotocin (STZ, 200 mg/kg, via intraperitoneal injection) exhibited pathological alterations, including reduced respiratory exchange ratio, dampened fractional shortening and ejection fraction, increased left ventricular end-systolic and diastolic diameters, cardiac remodeling, cardiomyocyte contractile anomalies, intracellular Ca2+ defects, myocardial ultrastructural injury, oxidative stress, apoptosis, and mitochondrial damage, which were overtly attenuated or accentuated by ALDH2 overexpression or knockout, respectively. Diabetic patients also exhibited reduced plasma ALDH2 activity, cardiac remodeling, and diastolic dysfunction. In addition, STZ challenge altered expression levels of mitochondrial proteins (PGC-1α and UCP2) and Ca2+ regulatory proteins (SERCA, Na+–Ca2+ exchanger, and phospholamban), dampened autophagy and mitophagy (LC3B ratio, TOM20, Parkin, FUNDC1, and BNIP3), disrupted phosphorylation of Akt, GSK3β, and Foxo3a, and elevated PTEN phosphorylation, most of which were reversed or worsened by ALDH2 overexpression or knockout, respectively. Furthermore, the novel ALDH2 activator torezolid, as well as the classical ALDH2 activator Alda-1, protected against STZ- or high glucose-induced in vivo or in vitro cardiac anomalies, which was nullified by inhibition of Akt, GSK3β, Parkin, or mitochondrial coupling. Our data discerned a vital role for ALDH2 in diabetic cardiomyopathy possibly through regulation of Akt and GSK3β activation, Parkin mitophagy, and mitochondrial function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital Fudan University, Shanghai 710032, China.
- National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.
- Department of Cardiovascular Surgery, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
- Cardiovascular Department, Shanghai Xuhui Central Hospital, Fudan University, Shanghai 200031, China.
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences and Medicine, Northwest University, Xi'an 710069, China.
Förderung
- Guangdong Province and the Ministry
- Scientific Research Initiation Project of Guangdong Provincial Hospital of Traditional Chinese Medicine
- Fundamental and Applied Research
- Program of Shanghai Academic/Technology Research Leader
Zitieren
APA
Zhang, Y., Zou, R., Abudureyimu, M., Liu, Q., Ma, J., Xu, H., Yu, W., Yang, J., Jia, J., Qian, S., Wang, H., Yang, Y., Wang, X., Fan, X., & Ren, J. (2024). Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3 β -mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjad056
Vancouver
Zhang Y, Zou R, Abudureyimu M, Liu Q, Ma J, Xu H, et al. Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3 β -mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy. Journal of Molecular Cell Biology. 2024. doi:10.1093/jmcb/mjad056
BibTeX
@article{Zhang2024,
author = {Zhang, Yingmei and Zou, Rongjun and Abudureyimu, Miyesaier and Liu, Qiong and Ma, Jipeng and Xu, Haixia and Yu, Wei and Yang, Jian and Jia, Jianguo and Qian, Sanli and Wang, Haichang and Yang, Yang and Wang, Xin and Fan, Xiaoping and Ren, Jun},
title = {Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3 β -mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy},
journal = {Journal of Molecular Cell Biology},
year = {2024},
doi = {10.1093/jmcb/mjad056}
}
EUVIMED